CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net (loss) income after equity in losses from unconsolidated affiliates	$ (17,217)	$ 131
Adjustments to reconcile net (loss) income to cash (used in) provided by operating activities:
Depreciation and amortization	8,041	3,759
Non-cash impact of operating leases	1,431	1,126
Deferred income tax expense (benefit)	1,268	(2,078)
Stock-based compensation	6,930	3,625
Equity in losses of unconsolidated affiliates	300	455
Amortization of debt discount and issuance costs	4,573	282
Other losses	62	340
Changes in operating assets and liabilities (net of the effect of acquisitions):
Accounts receivable	(1,813)	2,808
Inventories	(3,901)	(438)
Other assets	(1,423)	(3,113)
Accounts payable	(2,708)	(2,491)
Due to related parties	0	(226)
Other liabilities	(3,644)	(7,456)
Net cash used in operating activities	(8,101)	(3,276)
Cash flows from investing activities:
Investment in subsidiary, net of cash acquired	0	(622)
Purchases of property and equipment	(486)	(722)
Net cash used in investing activities	(120,043)	(1,344)
Cash flows from financing activities:
Borrowings on line of credit	0	6,750
Repayments of line of credit borrowings	0	(12,750)
Payment of debt issuance costs	0	(3,072)
Payment of preferred stock issuance costs	(214)	0
Preferred stock proceeds	122,000	0
Convertible debt proceeds	0	86,250
Proceeds from issuance of common stock	2,050	1,233
Repurchase of common stock	(652)	(3,480)
Repayments of other debt	(193)	(1,164)
Borrowings on other debts	508	0
Net cash provided by financing activities	123,499	73,767
Foreign exchange effect on cash and cash equivalents	123	(31)
Net increase (decrease) in cash and cash equivalents	(4,522)	69,116
Cash and cash equivalents, beginning of period	89,030	13,389
Cash and cash equivalents, end of period	84,508	82,505
Supplemental disclosure of cash flow information:
Non-cash transfers of equipment between inventory and property and equipment, net	3,328	1,118
Non-cash conversion of preferred stock to common stock	122,000	0
Accrued debt issuance costs	0	105
Purchase price adjustment receivable for scil	1,273	0
Capex purchases - accrued but unpaid	40	0
CVM
Cash flows from investing activities:
Acquisition of CVM	(14,420)	0
Scil Animal Care Company
Cash flows from investing activities:
Acquisition of CVM	$ (105,137)	$ 0